Over the past 20 years, while the price of a gallon of milk climbed 23 percent and the sticker on a Dodge Caravan minivan rose 21 percent, the list price of the insulin Humalog shot up 1,157 percent.
Jason Vasquez has helped DeveloperTown grow from a small design and development shop working primarily with startups to a well-established agency working with Fortune 500 companies.
A local company that leases Google Glass devices and sells software on top of it expects revenue to jump from an estimated $1.4 million this year to about $11 million next year.
Global pharmaceutical companies including Indianapolis-based Eli Lilly and Co. are heading into smaller cities and rural areas to learn about the health care needs of about 70 percent of India’s population.
The parent company of Circle Centre mall’s sole anchor, Carson’s, is facing steep challenges, with some retail experts wondering whether it will be the next big chain to collapse.
The trustee charges that Sam Odle and fellow outside directors should have ousted CEO Kevin Modany—a move that likely would have been well-received by the U.S. Department of Education and ITT’s accrediting agency.
Drugmakers like Eli Lilly and Co. plunged off a patent cliff earlier this decade, losing billions in sales as lucrative branded drugs lost exclusivity. An expensive lobbying effort aimed at preventing a repeat is paying off.
Eli Lilly and Co. announced the “strategic research collaboration” Thursday morning, calling it the largest agreement of its kind between Purdue and a single company.
A growing number of Indiana corporations are formalizing in-house innovation, an effort aimed at remaining technologically relevant in a fast-changing business landscape.
As medicines—especially those that treat conditions such as anxiety or depression—are becoming more complex, it’s not just the mix of active ingredients that generic drugmakers have to replicate. It’s also the release mechanism.
The companies say the drug, now in late-stage clinical trials, could be more effective for pain treatment than opioids—a dangerous category of pain killers that includes hydrocodone, morphine and fentanyl—without the abuse potential of such medications.
Indiana already has a burgeoning aerospace industry with players such as Rolls-Royce, GE Aviation, and Raytheon Co., but economic development officials say further growth is possible.
America's three insulin manufacturers—Indianapolis-based Eli Lilly and Co., Sanofi and Novo Nordisk—would face fines of $5,000 daily if they fail to provide the data.
An embattled industry is pushing back against complaints of high drug prices, constant drug advertising and companies that don’t invest enough in research. Here’s a Q&A with Stephen Ubl, CEO of the industry’s trade group.
A set of consolidated lawsuits accuse AbbVie and other makers of testosterone-replacement medicines, including Eli Lilly and Co., of hiding or downplaying their products’ risk for blood clots or other serious injuries.
